0000911916-15-000306.txt : 20150806
0000911916-15-000306.hdr.sgml : 20150806
20150806140059
ACCESSION NUMBER: 0000911916-15-000306
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150804
FILED AS OF DATE: 20150806
DATE AS OF CHANGE: 20150806
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CoLucid Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001348649
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203419541
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 781-365-2596
MAIL ADDRESS:
STREET 1: 222 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Colucid Pharmaceuticals Inc
DATE OF NAME CHANGE: 20060104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dallas Matthew D
CENTRAL INDEX KEY: 0001612396
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37358
FILM NUMBER: 151032339
MAIL ADDRESS:
STREET 1: AVEO PHARMACEUTICALS, INC.
STREET 2: 650 EAST KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-08-04
0001348649
CoLucid Pharmaceuticals, Inc.
CLCD
0001612396
Dallas Matthew D
15 NEW ENGLAND EXECUTIVE PARK
BURLINGTON
MA
01803
0
1
0
0
Chief Financial Officer
Employee Stock Option (Right to Buy)
7.56
2015-08-04
4
A
0
30000
0
A
2025-08-04
Common Stock
30000
30000
D
Options vest as to one-fourth of the shares on August 4, 2016 and as to the remaining shares in a series of 36 successive equal monthly installments upon completion of each additional month of service.
/s/ Miranda S. Hirner, Attorney-in-Fact for Matthew D. Dallas (power of attorney previously filed)
2015-08-06